Characterization of autoantibodies generated in mice by immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins

The R13 peptide sequence (EEEDDDMGFGLFD) that corresponds to the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins differs from the eukariotic P consensus sequence EESDDDMGFGLFD (H13) only in a nonconservative amino acid substitution. Since the immunization with R13 peptide coupled...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.) Fla.), 1999-04, Vol.91 (1), p.17-24
Hauptverfasser: MOTRAN, C. C, CERBAN, F. M, RIVAROLA, H. W, DE CIMA, E. V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 24
container_issue 1
container_start_page 17
container_title Clinical immunology (Orlando, Fla.)
container_volume 91
creator MOTRAN, C. C
CERBAN, F. M
RIVAROLA, H. W
DE CIMA, E. V
description The R13 peptide sequence (EEEDDDMGFGLFD) that corresponds to the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins differs from the eukariotic P consensus sequence EESDDDMGFGLFD (H13) only in a nonconservative amino acid substitution. Since the immunization with R13 peptide coupled to a carrier protein like OVA would break the tolerance to a self-sequence and generate autoantibodies, we characterized the antibodies induced in mice by R13 immunization, analyzing by ELISA their capacity to bind to R13 and the self-sequence H13. Besides, we studied the course of these reactivities a long time after immunization. It was found that all R13-immunized mice had antibodies against H13 and this reactivity was always lower than R13 reactivity. The anti-H13 reactivity evaluated by competitive ELISA demonstrated that the H13 peptide is able to inhibit the binding of immune sera to R13 at high doses. When the levels and the avidity of anti-R13 and anti-H13 were evaluated at 10 and 80 days post third immunization, it was observed that anti-R13 levels were higher than anti-H13 levels in all sera from 10 days after the third immunization. However, avidity of both antibodies was high. In sera from 80 days post third immunization, anti-R13 and anti-H13 levels and avidity either remained elevated or showed a rise, whereas anti-OVA levels declined. Moreover, when ECG traces were obtained from immunized mice, the heart functional alterations observed at 10 days continued at 80 days after the third immunization, showing an association with the levels of the antibodies. In addition, the isotype pattern that recognizes R13 and the self-sequence H13 is different. For anti-R13 response, IgG1 reactivity was higher than IgG2; meanwhile, for anti-H13 response IgG2 reactivity was higher than IgG1. These results indicate that sera from R13-immunized mice bind the H13 sequence and this autoreactivity may be self-perpetuating.
doi_str_mv 10.1006/clim.1998.4678
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_17293764</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17293764</sourcerecordid><originalsourceid>FETCH-LOGICAL-p236t-d33cb748cce99ff70c03bf927884152ff7bd02819bc5f49f6b27ad76638a44123</originalsourceid><addsrcrecordid>eNpFkEtLxDAQgIMo7vq4epQcxFvXPNqkOcriCxb0oOcyTdPdSJOuSYqs_8J_bMUunubBN98wg9AFJQtKiLjRnXULqlS5yIUsD9CcFoxmkvDicMqFoGKGTmJ8J4QUjIljNKOEUcUKMkffyw0E0MkE-wXJ9h73LYYh9eCTrfvGmojXxpsAyTTYeuysNrjeYevc4PcznzZtcNoYvMxGk7MeOhzMetK9ht0WfB97B1iH4cviMKp_yw6_UAy-wS8Mb0OfjPXxDB210EVzPsVT9HZ_97p8zFbPD0_L21W2ZVykrOFc1zIvtTZKta0kmvC6VUyWZT7ePXbqhrCSqloXba5aUTMJjRSCl5DnlPFTdP3nHRd_DCamytmoTdeBN_0QKyqZ4lLkI3g5gUPtTFNtg3UQdtX-iSNwNQEQNXRtAK9t_OdKKpUi_AcwjINb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17293764</pqid></control><display><type>article</type><title>Characterization of autoantibodies generated in mice by immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>MOTRAN, C. C ; CERBAN, F. M ; RIVAROLA, H. W ; DE CIMA, E. V</creator><creatorcontrib>MOTRAN, C. C ; CERBAN, F. M ; RIVAROLA, H. W ; DE CIMA, E. V</creatorcontrib><description>The R13 peptide sequence (EEEDDDMGFGLFD) that corresponds to the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins differs from the eukariotic P consensus sequence EESDDDMGFGLFD (H13) only in a nonconservative amino acid substitution. Since the immunization with R13 peptide coupled to a carrier protein like OVA would break the tolerance to a self-sequence and generate autoantibodies, we characterized the antibodies induced in mice by R13 immunization, analyzing by ELISA their capacity to bind to R13 and the self-sequence H13. Besides, we studied the course of these reactivities a long time after immunization. It was found that all R13-immunized mice had antibodies against H13 and this reactivity was always lower than R13 reactivity. The anti-H13 reactivity evaluated by competitive ELISA demonstrated that the H13 peptide is able to inhibit the binding of immune sera to R13 at high doses. When the levels and the avidity of anti-R13 and anti-H13 were evaluated at 10 and 80 days post third immunization, it was observed that anti-R13 levels were higher than anti-H13 levels in all sera from 10 days after the third immunization. However, avidity of both antibodies was high. In sera from 80 days post third immunization, anti-R13 and anti-H13 levels and avidity either remained elevated or showed a rise, whereas anti-OVA levels declined. Moreover, when ECG traces were obtained from immunized mice, the heart functional alterations observed at 10 days continued at 80 days after the third immunization, showing an association with the levels of the antibodies. In addition, the isotype pattern that recognizes R13 and the self-sequence H13 is different. For anti-R13 response, IgG1 reactivity was higher than IgG2; meanwhile, for anti-H13 response IgG2 reactivity was higher than IgG1. These results indicate that sera from R13-immunized mice bind the H13 sequence and this autoreactivity may be self-perpetuating.</description><identifier>ISSN: 1521-6616</identifier><identifier>EISSN: 1521-7035</identifier><identifier>DOI: 10.1006/clim.1998.4678</identifier><identifier>PMID: 10219250</identifier><identifier>CODEN: CLIIFY</identifier><language>eng</language><publisher>San Diego, CA: Elsevier</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies, Protozoan - biosynthesis ; Antibodies, Protozoan - blood ; Antibody Affinity ; Antigens, Protozoan - administration &amp; dosage ; Antigens, Protozoan - genetics ; Autoantibodies - biosynthesis ; Autoantibodies - blood ; Biological and medical sciences ; Female ; Human protozoal diseases ; Immunization ; Immunoglobulin Isotypes - biosynthesis ; Immunoglobulin Isotypes - blood ; Infectious diseases ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Parasitic diseases ; Peptide Fragments - administration &amp; dosage ; Peptide Fragments - genetics ; Peptide Fragments - immunology ; Phosphoproteins - administration &amp; dosage ; Phosphoproteins - genetics ; Phosphoproteins - immunology ; Protozoal diseases ; Protozoan Proteins - administration &amp; dosage ; Protozoan Proteins - genetics ; Protozoan Proteins - immunology ; Ribosomal Proteins - administration &amp; dosage ; Ribosomal Proteins - genetics ; Ribosomal Proteins - immunology ; Trypanosoma cruzi ; Trypanosoma cruzi - genetics ; Trypanosoma cruzi - immunology ; Trypanosomiasis</subject><ispartof>Clinical immunology (Orlando, Fla.), 1999-04, Vol.91 (1), p.17-24</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1817990$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10219250$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MOTRAN, C. C</creatorcontrib><creatorcontrib>CERBAN, F. M</creatorcontrib><creatorcontrib>RIVAROLA, H. W</creatorcontrib><creatorcontrib>DE CIMA, E. V</creatorcontrib><title>Characterization of autoantibodies generated in mice by immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins</title><title>Clinical immunology (Orlando, Fla.)</title><addtitle>Clin Immunol</addtitle><description>The R13 peptide sequence (EEEDDDMGFGLFD) that corresponds to the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins differs from the eukariotic P consensus sequence EESDDDMGFGLFD (H13) only in a nonconservative amino acid substitution. Since the immunization with R13 peptide coupled to a carrier protein like OVA would break the tolerance to a self-sequence and generate autoantibodies, we characterized the antibodies induced in mice by R13 immunization, analyzing by ELISA their capacity to bind to R13 and the self-sequence H13. Besides, we studied the course of these reactivities a long time after immunization. It was found that all R13-immunized mice had antibodies against H13 and this reactivity was always lower than R13 reactivity. The anti-H13 reactivity evaluated by competitive ELISA demonstrated that the H13 peptide is able to inhibit the binding of immune sera to R13 at high doses. When the levels and the avidity of anti-R13 and anti-H13 were evaluated at 10 and 80 days post third immunization, it was observed that anti-R13 levels were higher than anti-H13 levels in all sera from 10 days after the third immunization. However, avidity of both antibodies was high. In sera from 80 days post third immunization, anti-R13 and anti-H13 levels and avidity either remained elevated or showed a rise, whereas anti-OVA levels declined. Moreover, when ECG traces were obtained from immunized mice, the heart functional alterations observed at 10 days continued at 80 days after the third immunization, showing an association with the levels of the antibodies. In addition, the isotype pattern that recognizes R13 and the self-sequence H13 is different. For anti-R13 response, IgG1 reactivity was higher than IgG2; meanwhile, for anti-H13 response IgG2 reactivity was higher than IgG1. These results indicate that sera from R13-immunized mice bind the H13 sequence and this autoreactivity may be self-perpetuating.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies, Protozoan - biosynthesis</subject><subject>Antibodies, Protozoan - blood</subject><subject>Antibody Affinity</subject><subject>Antigens, Protozoan - administration &amp; dosage</subject><subject>Antigens, Protozoan - genetics</subject><subject>Autoantibodies - biosynthesis</subject><subject>Autoantibodies - blood</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Human protozoal diseases</subject><subject>Immunization</subject><subject>Immunoglobulin Isotypes - biosynthesis</subject><subject>Immunoglobulin Isotypes - blood</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Parasitic diseases</subject><subject>Peptide Fragments - administration &amp; dosage</subject><subject>Peptide Fragments - genetics</subject><subject>Peptide Fragments - immunology</subject><subject>Phosphoproteins - administration &amp; dosage</subject><subject>Phosphoproteins - genetics</subject><subject>Phosphoproteins - immunology</subject><subject>Protozoal diseases</subject><subject>Protozoan Proteins - administration &amp; dosage</subject><subject>Protozoan Proteins - genetics</subject><subject>Protozoan Proteins - immunology</subject><subject>Ribosomal Proteins - administration &amp; dosage</subject><subject>Ribosomal Proteins - genetics</subject><subject>Ribosomal Proteins - immunology</subject><subject>Trypanosoma cruzi</subject><subject>Trypanosoma cruzi - genetics</subject><subject>Trypanosoma cruzi - immunology</subject><subject>Trypanosomiasis</subject><issn>1521-6616</issn><issn>1521-7035</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtLxDAQgIMo7vq4epQcxFvXPNqkOcriCxb0oOcyTdPdSJOuSYqs_8J_bMUunubBN98wg9AFJQtKiLjRnXULqlS5yIUsD9CcFoxmkvDicMqFoGKGTmJ8J4QUjIljNKOEUcUKMkffyw0E0MkE-wXJ9h73LYYh9eCTrfvGmojXxpsAyTTYeuysNrjeYevc4PcznzZtcNoYvMxGk7MeOhzMetK9ht0WfB97B1iH4cviMKp_yw6_UAy-wS8Mb0OfjPXxDB210EVzPsVT9HZ_97p8zFbPD0_L21W2ZVykrOFc1zIvtTZKta0kmvC6VUyWZT7ePXbqhrCSqloXba5aUTMJjRSCl5DnlPFTdP3nHRd_DCamytmoTdeBN_0QKyqZ4lLkI3g5gUPtTFNtg3UQdtX-iSNwNQEQNXRtAK9t_OdKKpUi_AcwjINb</recordid><startdate>19990401</startdate><enddate>19990401</enddate><creator>MOTRAN, C. C</creator><creator>CERBAN, F. M</creator><creator>RIVAROLA, H. W</creator><creator>DE CIMA, E. V</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope></search><sort><creationdate>19990401</creationdate><title>Characterization of autoantibodies generated in mice by immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins</title><author>MOTRAN, C. C ; CERBAN, F. M ; RIVAROLA, H. W ; DE CIMA, E. V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p236t-d33cb748cce99ff70c03bf927884152ff7bd02819bc5f49f6b27ad76638a44123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies, Protozoan - biosynthesis</topic><topic>Antibodies, Protozoan - blood</topic><topic>Antibody Affinity</topic><topic>Antigens, Protozoan - administration &amp; dosage</topic><topic>Antigens, Protozoan - genetics</topic><topic>Autoantibodies - biosynthesis</topic><topic>Autoantibodies - blood</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Human protozoal diseases</topic><topic>Immunization</topic><topic>Immunoglobulin Isotypes - biosynthesis</topic><topic>Immunoglobulin Isotypes - blood</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Parasitic diseases</topic><topic>Peptide Fragments - administration &amp; dosage</topic><topic>Peptide Fragments - genetics</topic><topic>Peptide Fragments - immunology</topic><topic>Phosphoproteins - administration &amp; dosage</topic><topic>Phosphoproteins - genetics</topic><topic>Phosphoproteins - immunology</topic><topic>Protozoal diseases</topic><topic>Protozoan Proteins - administration &amp; dosage</topic><topic>Protozoan Proteins - genetics</topic><topic>Protozoan Proteins - immunology</topic><topic>Ribosomal Proteins - administration &amp; dosage</topic><topic>Ribosomal Proteins - genetics</topic><topic>Ribosomal Proteins - immunology</topic><topic>Trypanosoma cruzi</topic><topic>Trypanosoma cruzi - genetics</topic><topic>Trypanosoma cruzi - immunology</topic><topic>Trypanosomiasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MOTRAN, C. C</creatorcontrib><creatorcontrib>CERBAN, F. M</creatorcontrib><creatorcontrib>RIVAROLA, H. W</creatorcontrib><creatorcontrib>DE CIMA, E. V</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Clinical immunology (Orlando, Fla.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MOTRAN, C. C</au><au>CERBAN, F. M</au><au>RIVAROLA, H. W</au><au>DE CIMA, E. V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of autoantibodies generated in mice by immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins</atitle><jtitle>Clinical immunology (Orlando, Fla.)</jtitle><addtitle>Clin Immunol</addtitle><date>1999-04-01</date><risdate>1999</risdate><volume>91</volume><issue>1</issue><spage>17</spage><epage>24</epage><pages>17-24</pages><issn>1521-6616</issn><eissn>1521-7035</eissn><coden>CLIIFY</coden><abstract>The R13 peptide sequence (EEEDDDMGFGLFD) that corresponds to the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins differs from the eukariotic P consensus sequence EESDDDMGFGLFD (H13) only in a nonconservative amino acid substitution. Since the immunization with R13 peptide coupled to a carrier protein like OVA would break the tolerance to a self-sequence and generate autoantibodies, we characterized the antibodies induced in mice by R13 immunization, analyzing by ELISA their capacity to bind to R13 and the self-sequence H13. Besides, we studied the course of these reactivities a long time after immunization. It was found that all R13-immunized mice had antibodies against H13 and this reactivity was always lower than R13 reactivity. The anti-H13 reactivity evaluated by competitive ELISA demonstrated that the H13 peptide is able to inhibit the binding of immune sera to R13 at high doses. When the levels and the avidity of anti-R13 and anti-H13 were evaluated at 10 and 80 days post third immunization, it was observed that anti-R13 levels were higher than anti-H13 levels in all sera from 10 days after the third immunization. However, avidity of both antibodies was high. In sera from 80 days post third immunization, anti-R13 and anti-H13 levels and avidity either remained elevated or showed a rise, whereas anti-OVA levels declined. Moreover, when ECG traces were obtained from immunized mice, the heart functional alterations observed at 10 days continued at 80 days after the third immunization, showing an association with the levels of the antibodies. In addition, the isotype pattern that recognizes R13 and the self-sequence H13 is different. For anti-R13 response, IgG1 reactivity was higher than IgG2; meanwhile, for anti-H13 response IgG2 reactivity was higher than IgG1. These results indicate that sera from R13-immunized mice bind the H13 sequence and this autoreactivity may be self-perpetuating.</abstract><cop>San Diego, CA</cop><pub>Elsevier</pub><pmid>10219250</pmid><doi>10.1006/clim.1998.4678</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1521-6616
ispartof Clinical immunology (Orlando, Fla.), 1999-04, Vol.91 (1), p.17-24
issn 1521-6616
1521-7035
language eng
recordid cdi_proquest_miscellaneous_17293764
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Amino Acid Sequence
Animals
Antibodies, Protozoan - biosynthesis
Antibodies, Protozoan - blood
Antibody Affinity
Antigens, Protozoan - administration & dosage
Antigens, Protozoan - genetics
Autoantibodies - biosynthesis
Autoantibodies - blood
Biological and medical sciences
Female
Human protozoal diseases
Immunization
Immunoglobulin Isotypes - biosynthesis
Immunoglobulin Isotypes - blood
Infectious diseases
Medical sciences
Mice
Mice, Inbred BALB C
Parasitic diseases
Peptide Fragments - administration & dosage
Peptide Fragments - genetics
Peptide Fragments - immunology
Phosphoproteins - administration & dosage
Phosphoproteins - genetics
Phosphoproteins - immunology
Protozoal diseases
Protozoan Proteins - administration & dosage
Protozoan Proteins - genetics
Protozoan Proteins - immunology
Ribosomal Proteins - administration & dosage
Ribosomal Proteins - genetics
Ribosomal Proteins - immunology
Trypanosoma cruzi
Trypanosoma cruzi - genetics
Trypanosoma cruzi - immunology
Trypanosomiasis
title Characterization of autoantibodies generated in mice by immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A24%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20autoantibodies%20generated%20in%20mice%20by%20immunization%20with%20the%20C-terminal%20region%20of%20Trypanosoma%20cruzi%20ribosomal%20P1%20and%20P2%20proteins&rft.jtitle=Clinical%20immunology%20(Orlando,%20Fla.)&rft.au=MOTRAN,%20C.%20C&rft.date=1999-04-01&rft.volume=91&rft.issue=1&rft.spage=17&rft.epage=24&rft.pages=17-24&rft.issn=1521-6616&rft.eissn=1521-7035&rft.coden=CLIIFY&rft_id=info:doi/10.1006/clim.1998.4678&rft_dat=%3Cproquest_pubme%3E17293764%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17293764&rft_id=info:pmid/10219250&rfr_iscdi=true